Bastiaan Nuijen - Concepedia

Author

Bastiaan Nuijen

The Netherlands Cancer Institute ORCID

Also Known As

B NUIJEN, B Nuijen, B. Nuijen, Bastiaan Nuijen, J Coen Van Hasselt

169

Publications

4.5K

Citations

H-Index

122

Concepts

All Affiliations

The Netherlands Cancer Institute Slotervaartziekenhuis Utrecht University Oncode Institute University Medical Center Utrecht

About

Bastiaan Nuijen is an author at The Netherlands Cancer Institute specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	42	1.9K
2	Engineering	11	11	425
3	Natural Sciences	6	6	170
4	Health Sciences	3	3	110
5	Public Health	1	1	18

Bastiaan Nuijen

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma Maartje W. Rohaan, Troels Holz Borch, Joost H. van den Berg, New England Journal of Medicine	2022	474
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential Liqin Wang, Rodrigo Leite de Oliveira, Sanne C.F.A. Huijberts, Cell Tumor BiologyAcquired VulnerabilityMedicinePhotocarcinogenesisMelanoma	2018	336
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs Daphne van der Velden, Louisa R. Hoes, Hanneke van der Wijngaart, Nature Drug RepositioningOncologyPreclinical Drug EvaluationDrug RepurposingPharmacology	2019	252
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up Joost H. van den Berg, Bianca Heemskerk, Nienke van Rooij, Journal for ImmunoTherapy of Cancer	2020	184
Management of Hot Flashes in Patients Who Have Breast Cancer With Venlafaxine and Clonidine: A Randomized, Double-Blind, Placebo-Controlled Trial Annelies H. Boekhout, Andrew Vincent, Otilia Dalesio, Journal of Clinical Oncology	2011	112
Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001) Johannes J. Moes, Stijn L.W. Koolen, Alwin D. R. Huitema, International Journal of Pharmaceutics Pharmaceutical DevelopmentPharmaceutical SciencePreliminary Clinical TestingExcipientsPharmacology	2011	104
Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial Mascha Nuijten, Peter Blanken, Ben van de Wetering, The Lancet Substance AbuseSubstance UseChronic Cocaine-dependent PatientsAddiction TreatmentAddiction	2016	86
Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site Maud Kamal, Sonia Lameiras, Marc Deloger, British Journal of Cancer	2020	83
Complement activation by PEGylated liposomes containing prednisolone Jolanda M. van den Hoven, Réka Nemes, Josbert M. Metselaar, European Journal of Pharmaceutical Sciences Complement SystemImmunologyEndocytic PathwayCellular BiochemistryImmunotherapy	2013	75
Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel Johannes J. Moes, Stijn L.W. Koolen, Alwin D. R. Huitema, European Journal of Pharmaceutics and Biopharmaceutics Polymer-drug ConjugateMedicineLow-dose Metronomic ChemotherapyPharmacologyMetronomic Therapy	2012	73

Page 1